Cas:6947-75-7 (1-BENZYL-4-OXO-PIPERIDIN-3-YL)-ACETIC ACID ETHYL ESTER manufacturer & supplier

Chemical Name:(1-BENZYL-4-OXO-PIPERIDIN-3-YL)-ACETIC ACID ETHYL ESTER

CAS.NO:6947-75-7

Synonyms:Ethyl (1-benzyl-4-oxo-3-piperidinyl)acetate;(1-BENZYL-4-OXO-PIPERIDIN-3-YL)-ACETIC ACID ETHYL ESTER

Molecular Formula:C₁₆H₂₁NO₃

Molecular Weight:275.34300

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:392.5ºC at 760 mmHg

Density:1.117g/cm3

Index of Refraction:1.531

PSA:46.61000

Exact Mass:275.15200

LogP:1.96870

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Ethyl (1-benzyl-4-oxo-3-piperidinyl)acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1-BENZYL-4-OXO-PIPERIDIN-3-YL)-ACETIC ACID ETHYL ESTER physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1-BENZYL-4-OXO-PIPERIDIN-3-YL)-ACETIC ACID ETHYL ESTER Use and application,Ethyl (1-benzyl-4-oxo-3-piperidinyl)acetate technical grade,usp/ep/jp grade.

Related News: Darzalex has its own VRd combo trials, dubbed PERSEUS and CEPHEUS, which are testing a newly approved under-the-skin version of the J&J drug called Darzalex Faspro. The CEPHEUS trial appears to have just completed its primary analysis, according to a listing on ClinicalTrials.gov. (1-BENZYL-4-OXO-PIPERIDIN-3-YL)-ACETIC ACID ETHYL ESTER manufacturer With the continuous advancement of economic globalization, the division of labor and cooperation around the world has become increasingly apparent. The fine chemical industry has the foundation of global division of labor and cooperation due to its long and complex industrial chain. (1-BENZYL-4-OXO-PIPERIDIN-3-YL)-ACETIC ACID ETHYL ESTER supplier While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added. (1-BENZYL-4-OXO-PIPERIDIN-3-YL)-ACETIC ACID ETHYL ESTER vendor Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday. (1-BENZYL-4-OXO-PIPERIDIN-3-YL)-ACETIC ACID ETHYL ESTER factory While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added.